title: Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.
abstract: Shigella spp. are food- and water-borne pathogens that cause shigellosis, a severe diarrheal and dysenteric disease that is associated with a high morbidity and mortality in resource-poor countries. No licensed vaccine is available to prevent shigellosis. We have recently demonstrated that Shigella invasion plasmid antigens (Ipas), IpaB and IpaD, which are components of the bacterial type III secretion system (TTSS), can prevent infection in a mouse model of intranasal immunization and lethal pulmonary challenge. Because they are conserved across Shigella spp. and highly immunogenic, these proteins are excellent candidates for a cross-protective vaccine. Ideally, such a vaccine could be administered to humans orally to induce mucosal and systemic immunity. In this study, we investigated the immunogenicity and protective efficacy of Shigella IpaB and IpaD administered orally with a double mutant of the Escherichia coli heat labile toxin (dmLT) as a mucosal adjuvant. We characterized the immune responses induced by oral vs. intranasal immunization and the protective efficacy using a mouse pulmonary infection model. Serum IgG and fecal IgA against IpaB were induced after oral immunization. These responses, however, were lower than those obtained after intranasal immunization despite a 100-fold dosage increase. The level of protection induced by oral immunization with IpaB and IpaD was 40%, while intranasal immunization resulted in 90% protective efficacy. IpaB- and IpaD-specific IgA antibody-secreting cells in the lungs and spleen and T-cell-derived IL-2, IL-5, IL-17 and IL-10 were associated with protection. These results demonstrate the immunogenicity of orally administered IpaB and IpaD and support further studies in humans.
authors: Center for Vaccine Development and Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.
authors: Shannon J
authors: SJ
authors: Heine
authors: Jovita
authors: J
authors: Diaz-McNair
authors: Francisco J
authors: FJ
authors: Martinez-Becerra
authors: Shyamal P
authors: SP
authors: Choudhari
authors: John D
authors: JD
authors: Clements
authors: Wendy L
authors: WL
authors: Picking
authors: Marcela F
authors: MF
authors: Pasetti
mesh_terms: D000281:Administration, Intranasal; D000284:Administration, Oral; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000008:administration & dosage / Q000276:immunology*; D001426:Bacterial Proteins / Q000008:administration & dosage / Q000276:immunology*; D001427:Bacterial Toxins / Q000008:administration & dosage / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D004405:Dysentery, Bacillary / Q000276:immunology / Q000517:prevention & control*; D004768:Enterotoxins / Q000008:administration & dosage / Q000276:immunology; D029968:Escherichia coli Proteins / Q000008:administration & dosage / Q000276:immunology; D005260:Female; D018928:Immunity, Mucosal; D051379:Mice; D008807:Mice, Inbred BALB C; D022281:Shigella Vaccines / Q000008:administration & dosage / Q000276:immunology*; D012763:Shigella flexneri / Q000276:immunology*; D014611:Vaccination; D022223:Vaccines, Subunit / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D016207:Cytokines; D004768:Enterotoxins; D029968:Escherichia coli Proteins; C095770:IpaD protein, Shigella flexneri; D022281:Shigella Vaccines; D022223:Vaccines, Subunit; C087447:ipaB protein, Shigella; C027538:heat-labile enterotoxin, E coli
references: Vaccine. 2011 Sep 16;29(40):7009-19
references: 21787825
references: Vaccine. 2010 Feb 3;28(5):1404-11
references: 19897067
references: Infect Immun. 1999 Aug;67(8):3970-9
references: 10417163
references: Anal Biochem. 1992 Jan;200(1):74-80
references: 1595904
references: Lancet. 2012 Dec 15;380(9859):2095-128
references: 23245604
references: Infect Immun. 1997 Dec;65(12):5338-41
references: 9393836
references: Expert Rev Vaccines. 2009 Dec;8(12):1693-704
references: 19943764
references: N Engl J Med. 2004 Feb 26;350(9):896-903
references: 14985487
references: Infect Immun. 1996 Oct;64(10):4074-7
references: 8926071
references: J Immunol. 2009 Nov 1;183(9):5879-85
references: 19828639
references: Infect Immun. 2012 Mar;80(3):1222-31
references: 22202122
references: J Clin Microbiol. 1991 Feb;29(2):386-9
references: 1706731
references: PLoS One. 2009 Sep 16;4(9):e6999
references: 19756141
references: Clin Infect Dis. 1992 Aug;15(2):346-61
references: 1381621
references: Vaccine. 2006 May 1;24(18):3735-45
references: 16095766
references: Vaccine. 1995 Aug;13(11):1006-12
references: 8525683
references: Vaccine. 2011 Feb 1;29(6):1347-54
references: 21040694
references: Nat Rev Microbiol. 2007 Jul;5(7):540-53
references: 17558427
references: Infect Immun. 2002 Apr;70(4):2016-21
references: 11895966
references: J Infect Dis. 2004 Nov 15;190(10):1745-54
references: 15499528
references: Vaccine. 2013 Jan 7;31(3):452-60
references: 23153448
references: Hum Vaccin. 2007 Nov-Dec;3(6):268-75
references: 17938573
references: Lancet. 2012 Dec 15;380(9859):2197-223
references: 23245608
references: Curr Opin Allergy Clin Immunol. 2006 Jun;6(3):207-13
references: 16670516
references: J Immunol. 1986 Feb 1;136(3):1081-6
references: 3510252
references: Mucosal Immunol. 2009 Sep;2(5):403-11
references: 19587639
references: Vaccine. 2009 Jan 22;27(4):565-72
references: 19022324
references: PLoS One. 2012;7(5):e37722
references: 22655066
references: Vaccine. 2010 Mar 2;28(10):2231-2235
references: 20056180
references: Infect Immun. 2007 May;75(5):2626-9
references: 17296762
references: Annu Rev Immunol. 2009;27:485-517
references: 19132915
references: Am J Epidemiol. 1991 Sep 15;134(6):614-27
references: 1951266
references: Vaccine. 2001 Feb 28;19(15-16):1940-50
references: 11228364
references: Acta Microbiol Hung. 1992;39(3-4):263-70
references: 1343940
references: Vaccine. 1995 Apr;13(5):495-502
references: 7639017
references: J Immunol. 2010 Feb 15;184(4):2076-85
references: 20089698
references: J Infect Dis. 1992 Jul;166(1):158-61
references: 1607690
references: Infect Immun. 1991 Jul;59(7):2341-50
references: 2050402
references: Immunol Rev. 2011 Jan;239(1):125-48
references: 21198669
references: Gut. 1996 Mar;38(3):328-36
references: 8675083
references: J Clin Microbiol. 1993 Feb;31(2):454-7
references: 8432838
references: Vaccine. 2006 Mar 20;24(13):2290-301
references: 16364513
references: Clin Vaccine Immunol. 2010 Jun;17(6):1005-12
references: 20427625
references: Biochem Soc Trans. 1994 May;22(2):295-8
references: 7958310
references: Mucosal Immunol. 2010 Mar;3(2):159-71
references: 19924118
references: J Exp Med. 2012 Aug 27;209(9):1595-609
references: 22891275
references: Expert Rev Vaccines. 2006 Oct;5(5):669-86
references: 17181440
references: Infect Immun. 2006 Aug;74(8):4391-400
references: 16861624